PledPharma Appoints Advisor for the Commercialization of PledOx®

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Stockholm, 2013-05-06 08:30 CEST (GLOBE NEWSWIRE) -- PledPharma is looking to license PledOx to a major pharmaceutical company with a proven commitment to oncology. The deal structure is expected to include an upfront payment at signing and at key development milestones, followed by sales-based royalties.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC